Asia Pacific Malaria Treatment Market Forecast to 2030

At 30.1% CAGR, Asia Pacific Malaria Treatment Market is Speculated to be Worth US$ 5,179.15 Million by 2030, says the Research Team

According to the Research Team research, the Asia Pacific malaria treatment market was valued at US$ 631.37 million in 2022 and is expected to reach US$ 5,179.15 million by 2030, registering a CAGR of 30.1% from 2022 to 2030. Rising initiatives to raise awareness about malaria and increasing prevalence of malaria are among the critical factors attributed to the Asia Pacific malaria treatment market expansion.

Malaria awareness campaigns help enhance the knowledge of the population regarding the disease, thereby promoting healthcare services through intersectoral collaboration and social support. The WHO coordinates with the Global Malaria Programme (GMP) as part of its global efforts for controlling and eradicating malaria. The WHO also observes World Malaria Day on April 25 of every year to highlight the commitment of the communities dedicated to spreading awareness about malaria and its treatment and uniting for the common objective of eliminating malaria cases.

Governments of several countries are taking various initiatives to create awareness and conduct research for the development of new antimalarial drugs and vaccines. As per the WHO data, total funding for the control and elimination of malaria reached ~US$ 3 billion in 2019; the governments of endemic countries such as South Africa and Asia collectively contributed 31% (~US$ 900 million) of the total fund to create awareness and development of new vaccines for the treatment of the disease. Various private companies are also investing heavily in R&D activities to reduce the incidence of malaria.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the diseases by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy that aims to eliminate the disease by 2024.

Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

On the contrary, availability of counterfeit antimalarial drugs followed by subsequent drug resistance hurdles the growth of Asia Pacific malaria treatment market.

Based on treatment, the Asia Pacific malaria treatment market is categorized into generic drugs, originators, vaccines, and others. The vaccines segment held 96.6% share of Asia Pacific malaria treatment market in 2022, amassing US$ 609.85 million. It is projected to garner US$ 5,051.79 million by 2030 to expand at 30.3% CAGR during 2022-2030.

In terms of route of administration, the Asia Pacific malaria treatment market is bifurcated into oral and parenteral. The oral segment held 69.0% share of Asia Pacific malaria treatment market in 2022, amassing US$ 435.77 million. It is projected to garner US$ 3,524.79 million by 2030 to expand at 29.9% CAGR during 2022-2030.

By distribution channel, the Asia Pacific malaria treatment market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held 45.6% share of Asia Pacific malaria treatment market in 2022, amassing US$ 288.15 million. It is projected to garner US$ 2,371.99 million by 2030 to expand at 30.1% CAGR during 2022-2030.

Based on country, the Asia Pacific malaria treatment market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that the Rest of Asia Pacific captured 82.9% share of Asia Pacific malaria treatment market in 2022. It was assessed at US$ 523.09 million in 2022 and is likely to hit US$ 4,299.22 million by 2030, exhibiting a CAGR of 30.1% during 2022-2030.

Key players operating in the Asia Pacific malaria treatment market are Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, and Lupin Ltd, among others.

In November 2022, Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria.

In October 2021, GSK welcomes WHO recommendation for broad roll-out of its RTS,S/AS01e (RTS,S) malaria vaccine.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific malaria treatment market
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific malaria treatment market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights – Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Malaria Treatment Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Malaria
4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis
5. Malaria Treatment Market – Asia Pacific Market Analysis
5.1 Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6. Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 – by Treatment
6.1 Overview
6.2 Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
6.3.1 Overview
6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
6.4.1 Overview
6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
6.5.1 Overview
6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
6.6.1 Overview
6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)
7. Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
7.1 Overview
7.2 Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
7.4.1 Overview
7.4.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
8.1 Overview
8.2 Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
8.3.1 Overview
8.3.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
8.4.1 Overview
8.4.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
8.6 Online Pharmacies
8.6.1 Overview
8.6.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Malaria Treatment Market – Country Analysis
9.1 Asia Pacific Malaria Treatment Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.1.1 Asia Pacific: Malaria Treatment Market, by Countries
9.1.1.2 Japan
9.1.1.3 Overview
9.1.1.3.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 Japan: Malaria Treatment Market, by Treatment
9.1.1.3.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.3.4 Japan: Malaria Treatment Market, by Distribution Channel
9.1.1.3.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.3.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
9.1.1.4 India
9.1.1.5 Overview
9.1.1.5.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 India: Malaria Treatment Market, by Treatment
9.1.1.5.3 India: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.5.4 India: Malaria Treatment Market, by Distribution Channel
9.1.1.5.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.5.4.2 India: Malaria Treatment Market, by Retail Pharmacies
9.1.1.6 South Korea
9.1.1.7 Overview
9.1.1.7.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 South Korea: Malaria Treatment Market, by Treatment
9.1.1.7.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.7.4 South Korea: Malaria Treatment Market, by Distribution Channel
9.1.1.7.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.7.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
9.1.1.8 Australia
9.1.1.9 Overview
9.1.1.9.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.9.2 Australia: Malaria Treatment Market, by Treatment
9.1.1.9.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.9.4 Australia: Malaria Treatment Market, by Distribution Channel
9.1.1.9.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.9.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
9.1.1.10 Rest of Asia Pacific
9.1.1.11 Overview
9.1.1.11.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.11.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
9.1.1.11.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.11.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
9.1.1.11.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.11.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10. Malaria Treatment Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Cipla Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Service
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lupin Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 5. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 6. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 7. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 8. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 9. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 10. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 11. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 12. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 13. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 14. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 15. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 16. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 17. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 18. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 19. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 20. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 21. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 22. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 24. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 25. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 26. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 27. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 28. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 29. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 30. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 31. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 32. Glossary of Terms, Malaria Treatment Market
 

Figure 1. Malaria Treatment Market – Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 – 2030
Figure 4. Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Malaria Treatment Market, 2022 ($Mn)
Figure 19. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Malaria Treatment Market